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Sudden Cardiac Death (SCD) is a medical problem that is responsible for over 300,000 
deaths per year in the United States and millions worldwide.  SCD is defined as death 
occurring from within one hour of the onset of acute symptoms, an unwitnessed death in 
the absence of pre-existing progressive circulatory failures or other causes of deaths, or 
death during attempted resuscitation.  Sudden death due to cardiac reasons is a leading 
cause of death among Congestive Heart Failure (CHF) patients.  The use of Electronic 
Medical Records (EMR) systems has made a wealth of medical data available for research 
and analysis.  Supervised machine learning methods have been successfully used for 
medical diagnosis.  Ensemble classifiers are known to achieve better prediction accuracy 
than its constituent base classifiers.  In an effort to understand the factors contributing to 
SCD, data on 2,521 patients were collected for the Sudden Cardiac Death in Heart Failure 
Trial (SCD-HeFT).  The data included 96 features that were gathered over a period of 5 
years.  The goal of this dissertation was to develop a model that could accurately predict 
SCD based on available features.  The prediction model used the Cox proportional hazards 
model as a score and then used the ExtraTreesClassifier algorithm as a boosting mechanism 
to create the ensemble. We tested the system at prediction points of 180 days and 365 days.  
Our best results were at 180-days with accuracy of 0.9624, specificity of 0.9915, and F1 
score of 0.9607. 
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Sudden Cardiac Death (SCD) is one of the main clinical challenges in modern 
medicine (Shen, Shen, Lin, & Ou, 2007).  It is responsible for more than 300,000 
casualties in the United States and millions worldwide (Ebrahimzadeh, Pooyan, & Bijar, 
2014; Murukesan, Murugappan, & Iqbal, 2013; Murukesan, Murugappan, Iqbal, & 
Saravanan, 2014). 
SCD is defined as a witnessed death occurring within one hour of acute symptoms 
of cardiac events (Ayesta, Martínez-Sellés, de Luna, & Martínez-Sellés, 2018; Devi, 
Tyagi, & Kumar, 2016; Deyell, Krahn, & Goldberger, 2015; O'Mahony et al., 2014; 
Pascual-Figal et al., 2009; Ramírez, Orini, Mincholé, et al., 2017; Shiga et al., 2018), an 
unwitnessed death in the absence of pre-existing condition of circulatory failure (Pascual-
Figal et al., 2009), or death during resuscitation (Ayesta et al., 2018; Pascual-Figal et al., 
2009; Ramírez, Orini, Mincholé, et al., 2017; Shiga et al., 2018).  It is the result of 
precipitous loss of heart function (Murukesan et al., 2014; Shen et al., 2007) and is 
related to an electrical problem in the heart (Murukesan et al., 2014; Vanitha, Suresh, & 
JenefarSheela, 2014).  Most of the SCD incidents are related to arrhythmia or coronary 




Ayesta et al. (2018) stated that SCD could occur in any of the following 
population groups: 1) patients who were never diagnosed with heart disease; 2) patients 
who were diagnosed with heart disease but had no or mild cardiac dysfunction; 3) 
patients who were diagnosed with heart disease and had severe cardiac dysfunction; and 
4) patients who were diagnosed with cardiac arrhythmia due to a genetically-based cause.  
The data used in this dissertation satisfies the second group.   
Several factors can lead to SCD.  These included ventricular tachycardia (VT), 
ventricular flutter (VFL), ventricular fibrillation (VFib), left ventricular systolic 
dysfunction, arrhythmia, coronary heart diseases, previous heart attack, long QT-
syndrome, myocardial infarction, transient ischemia, heart failure, prolonged QRS 
duration, asystole, and obesity (U. Rajendra Acharya et al., 2015; Deyell et al., 2015; 
Ebrahimzadeh & Pooyan, 2011; Ebrahimzadeh et al., 2014; Eranti et al., 2016; Fishman 
et al., 2010; Goldberger et al., 2014; Kurbanov, Mullabaeva, & Kilichev, 2015; Lee, 
Shin, Seo, Nam, & Joo, 2016; Liew, 2011; Murugappan, Murukesan, Omar, Khatun, & 
Murugappan, 2015; Murukesan et al., 2013; Pascual-Figal et al., 2009; Piccini et al., 
2010; Shastri et al., 2012; Shen et al., 2007; Sotto, Coelho, & Melo, 2016; 
Vadakkumpadan, Trayanova, Younes, & Wu, 2012).  
Patients with New York Heart Association (NYHA) class II (mild) and class III 
(moderate) heart failure constitute a high-risk population for SCD (Bardy  et al., 2005; 
Ramírez, Orini, Mincholé, et al., 2017).  Congestive Heart Failure (CHF) is defined as the 
inability of the heart to pump enough blood to meet the body’s need (MedlinePlus, 




The prediction of SCD is based on two main approaches.  The first approach 
involves the study and analysis of electrocardiogram (ECG) and heart rate variability 
(HRV) signals in both normal and SCD-impacted subjects (U. Rajendra Acharya et al., 
2015; U Rajendra Acharya et al., 2015; Devi et al., 2016; Ebrahimzadeh & Pooyan, 2011; 
Ebrahimzadeh et al., 2014; Murugappan et al., 2015; Murukesan et al., 2013; Murukesan 
et al., 2014; Sheela & Vanitha, 2014; Shen et al., 2007; Toshniwal, Goel, & Sharma, 
2015; Vanitha et al., 2014).  This approach predicts SCD with a small lead time (in the 
minutes range) and can only benefit patients that are actually in the hospial.  Therefore, it 
was not considered for this dissertation.  The second approach involves gathering data 
through a clinical trial or a long-term study, then using statistical analyses or machine 
learning techniques for prediction (Adabag et al., 2014; Bardy  et al., 2005; Deyell et al., 
2015; Fan et al., 2014; Kurbanov et al., 2015; O'Mahony et al., 2014; Pascual-Figal et al., 
2009; Piccini et al., 2010; Shastri et al., 2012).  This dissertation used data from the 
Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) (Bardy  et al., 2005) to predict 
SCD in NYHA class II and class III patients. 
SCD prediction is formulated as a binary classification problem where a patient is 
classified as an SCD or non-SCD, based on observed input features.  No one algorithm is 
optimal for all problems (Johansson, Bostrom, & Karlsson, 2008).  Each algorithm has its 
strengths and weaknesses.  Ensemble classifiers are based on the idea of building a 
prediction model by combining the strengths of a collection of simpler base models 
(Hastie, Tibshirani, & Friedman, 2009).  The individual decisions of the classifiers that 




voting) to classify new examples (Dietterich, 2000).  This dissertation used ensemble 
classifiers to predict SCD in CHF patients. 
Problem Statement and Goal 
SCD has a high mortality rate (Ebrahimzadeh et al., 2014; Murukesan et al., 2013; 
Murukesan et al., 2014) and its early prediction is a challenge for the medical community 
(Shen et al., 2007).  Patients with congestive heart failure are more vulnerable to SCD 
(Bardy  et al., 2005).  The ability to accurately predict SCD is key to saving patients’ 
lives and reducing the mortality rate (Ebrahimzadeh et al., 2014; Murugappan et al., 
2015).   
In this dissertation, SCD prediction was formulated as a binary classification 
problem.  Given available data for a patient at a point in time, the goal was to predict 
SCD in NYHA class II and III heart failure patients within the next 180 days.  Data from 
Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) study was used to train and 
test the classifiers (Bardy  et al., 2005). 
Relevance and Significance 
The proposed research aimed to develop models to predict SCD within 180 days 
before its occurrence.  The key contribution of this dissertation was a prediction model 
for SCD for patients, using ensemble classifiers. 
SCD prediction has generated interest within the academic community in the last 
few years.  Extensive studies have been conducted in the SCD prediction area starting 




This dissertation developed an improved SCD prediction model using ensemble 
classification.  By combining time series prediction and ensemble classification, it was 
expected to achieve better results than the previously mentioned papers. 
Issues 
The data that was used in this dissertation came from a study that was not 
intended to be used for SCD prediction.  It was meant to be employed to compare the 
effectiveness of a couple of SCD treatment methods (Bardy  et al., 2005).  While it 
offered a clear definition of SCD cases, it required a lot of pre-processing in order for it 
to be used. 
The other issue was that the number of positive cases in the data was low with 
respect to the dataset.  This mandated the use of standard sampling techniques 
(Kotsiantis, Kanellopoulos, & Pintelas, 2006). 
Summary 
The goal of this dissertation was to increase the prediction accuracy of SCD for 
patients with NYHA class II and class III heart failure.  This was achieved using the Cox 
proportional hazard model as a score in the features list, then applying the 
ExtraTreesClassifier algorithm to generate the ensemble.  Data from the SCD-HeFT was 










The study of the cause and prediction of SCD has drawn the attention of many 
researchers.  This review covers the on-going research in SCD prediction and risk 
stratification.  Also, it provides an overview of ensemble classifiers and the use of the 
Cox model in the medical field. 
Sudden Cardiac Death 
 Huikuri et al. (2003) analyzed several techniques to predict arrhythmic deaths and 
suggested several measures of risk of sudden arrhythmic death.  Such measures include: 
Ejection Fraction (EF), ventricular arrhythmias, and ECG markers (Huikuri et al., 2003).  
These could be used as features in SCD prediction research. 
 Shen et al. (2007) developed a personal cardiac homecare system by sensing 
Lead-I ECG signals for detecting and predicting SCD events.  This system achieved 
87.5% accuracy and 75% sensitivity (Shen et al., 2007).  The study presented a machine 
learning prediction model and suggested a good feature to utilize. 
Pascual-Figal et al. (2009) studied whether the measurement of the soluble form 
of ST2 (sST2) could identify heart failure (HF).  ST2 is a protein biomarker of cardiac 
stress.  They demonstrated that elevated sST2 concentrations are predictive of SCD.  




 Piccini et al. (2010) investigated whether SCD factors could vary with time after a 
patient suffers myocardial infraction (MI).  They identified features, such as heart failure, 
stroke, atrial fibrillation, and hypertension, which could be used for SCD prediction. 
 Liew (2011) reviewed some of the evidence for ECG-based tests as predictors of 
SCD in patients with coronary artery disease (CAD).  The reviewed tests consisted of 12-
lead ECG, signal-averaged ECG, standard 24-hr Holter, heart rate variability, heart rate 
turbulence, and t-wave alternans.  He concluded that the 24-hr Holter test, combined with 
other parameters such as heart rate variability and heart rate turbulence, are the most 
promising features to predict SCD (Liew, 2011). 
 Stecker and Chugh (2011) and Vadakkumpadan et al. (2012) emphasized that left 
ventricular ejection fraction (LVEF) cannot be used as the sole predictor of SCD.  Any 
future research will need to include more features for SCD prediction. 
 Shastri et al. (2012) listed age, diabetes, peripheral vascular disease, ischemic 
heart disease, serum creatinine, and alkaline phosphatase as independent predictors of 
SCD.  They used Cox proportional hazard model with the mentioned features to assess 
the risk of suffering SCD.  The current dissertation investigated the use of Cox 
proportional hazard model in SCD prediction. 
 Sheela and Vanitha (2014) used a support vector machine classifier to predict 
SCD given HRV inputs.  The model was able to predict sudden cardiac arrest (SCA) 
before 30 minutes of its occurrence based on time and frequency domains features 
(Sheela & Vanitha, 2014).  SCD patients are those who suffered SCA and could not be 
revived (García Iglesias, Roqueñi Gutiérrez, De Cos, & Calvo, 2018).  In a similar effort, 




consisted of probability neural networks (PNN), K-nearest neighbor and support vector 
machine (SVM).  The decision of the three classifiers were combined using a simple 
voting system.  The model could predict sudden cardiac arrest (SCA) before 30 minutes 
of its occurrence based on time and frequency domains features.  The hybrid classifier 
achieved 90% prediction accuracy (Vanitha et al., 2014).  The use of machine learning 
techniques was the core of this dissertation. 
 Ebrahimzadeh et al. (2014) used linear, time-frequency and non-linear features 
that were extracted from HRV to predict SCD using K-nearest neighbor (KNN) and 
multilayer perception neural network (MLP).  Their results showed that the combination 
of features can predict SCD by the accuracy of 99.73%, 96.52%, 90.37% and 83.90% for 
the first, second, third and fourth one-minute intervals respectively, before SCD 
occurrence.  This study was used as a basis for model comparison. 
 Fan et al. (2014) conducted an observational study to determine the incidence and 
predicators of SCD in patients with LVEF ≤ 30% and New York Heart Association class 
II/III heart failure that were myocardial infraction (MI) survivors.  They concluded that 
SCD may be predicted by age, LVEF ≤ 25%, and non-revascularization. 
 Wellens et al. (2014) offered additional features for SCD prediction such as age, 
gender, ethnicity, blood pressure, heart rate, ischemic vs. non-ischemic cause, diabetes, 
kidney function, findings from cardiac imaging, electrical instability, ANS balance, 
biochemical markers, and the genetic profile.  These offered features are important for 
future SCD prediction models. 
 O'Mahony et al. (2014) developed an SCD prediction model that provided 




cardiomyopathy (HCM) cohort study and the model was developed using Cox 
proportional hazards model.  The key predictors were age, maximal left ventricular wall 
thickness, left atrial diameter, left ventricular overflow tract gradient, family history of 
SCD, non-sustained ventricular tachycardia, and unexplained syncope.  The study 
utilized Cox hazard model and offered SCD predictors. 
 Adabag et al. (2014) derived a prediction model for SCD that consisted of age, 
gender, history of diabetes mellitus, history of myocardial infraction, Left Bundle Branch 
Block (LBBB) on ECG, and natural logarithm NT-proBNP (lnNT-proBNP).  Their 
model was generated using Cox regression analysis. This is another study that 
demonstrated the use of Cox regression model.   
 Toshniwal et al. (2015) proposed a system to predict the risk of cardiovascular 
disease that can lead to SCD.  The system was based on ECG signals.  It consisted of a 2-
stage classification model where the first stage differentiated normal from abnormal 
records, while the second stage aimed to improve the accuracy by reducing the false 
negatives.  They used Random Forest with 120 trees for classification and achieved a 
98.57% accuracy.  The study showed the superiority of ensemble classification over 
single classification algorithms. 
 Deo et al. (2016) suggested 12 independent risk factors for SCD.  These were age, 
gender, race, use of smoking products, systolic blood pressure, use of antihypertensive 
medication, diabetes mellitus, serum potassium, serum albumin, high-density lipoprotein, 
estimated glomerular filtration rate, and QT interval.  Using such features, they 




in two different datasets.  The researchers demonstrated a different way of utilizing 
predictive features. 
Devi et al. (2016) used a KNN classifier to predict SCD one hour before its 
occurrence.  They used time and frequency domain features and compared the values of 
such features between affected and normal subjects.  Their model achieved 95% 
accuracy.  The researchers formulated another use of single classification.  
Lee et al. (2016) developed a prediction model for VT, which can lead to SCD.  
The model used artificial neural network (ANN) to predict the event one hour before its 
occurrence.  The dataset contained parameters that were obtained from heart rate 
variability and respiratory rate variability (RRV) analysis (Lee et al., 2016).  This study 
was used for model comparison. 
Weeks, Sieg, Gass, and Rajapreyar (2016) provided a review on drug therapies 
that aimed at suppressing arrhythmias that can cause sudden cardiac death in patients 
with heart failure.  They covered the SCD-HeFT trial and the effects of amiodarone.  
They also influenced the initial choice of some predictors. 
Rai and Agrawal (2016) provided a review that focused on the etiology, risk 
factors, prognostic features, and importance of risk stratification of SCD.  The key 
contribution of this research was the inclusion of multiple risk factors that were used as 
predictors. 
Al-Gobari, Le, Fall, Gueyffier, and Burnand (2017) attempted to assess the 
available evidence that evaluated the effectiveness of statins in clinical outcomes for 
heart failure patients.  The researchers concluded that while statins did not reduce SCD 




failure.  The presence of statins in a patient is a feature that was initially considered in 
this dissertation and this study added information about this subject. 
Ramírez, Orini, and Laguna (2017) used Cox hazard model with four different 
components of ECG to determine the component with the highest predictive value for 
SCD risk stratification.  They achieved that by calculating the hazard ration of each 
component. 
Desai et al. (2018) researched the effectiveness of the European Society of 
Cardiology’s (ESC) SCD risk score on the prognosis of obstructive hypertrophic 
cardiomyopathy (HCM) disease and assessed whether additional factors could adjust 
SCD risk.  The research was conducted on patients with obstructive HCM, a disease that 
causes the heart muscle to grow abnormally thick, which impacts the amount of blood the 
ventricular can hold and the amount pumped out with each heartbeat (Mayo Clinic, 
2018a).  This paper provided a 5-year lead time prediction model using the Cox 
proportional hazards analysis and helped verify the predictors’ list. 
Kubik, Dąbrowska-Kugacka, Lewicka, Daniłowicz-Szymanowicz, and Raczak 
(2018) provided a summary of the literature about left ventricular noncompaction 
(LVNC), which is a unique inherited cardiomyopathy characterized by an increased risk 
of heart failure, arrythmia, and SCD.  This paper helped in the choice of SCD predictors 
and introduced LVNC as a possible cause. 
Agoston-Coldea et al. (2018) utilized Cox proportional hazards regression to test 
the combined use of left ventricular global longitudinal strain (GLS) and Galectin-3 
(protein used as a marker of fibrosis where the latter is defined as the formation of excess 




aortic stenosis (AS).  This research effort benefited SCD because it is considered part of 
MACEs.  They concluded that GLS and the NT-proBNP (a prohormone used in the 
prognosis of heart failure) were the most reliable predictors of MACEs in patients with 
severe AS and were superior to Galectin-3. 
Shiga et al. (2018) used Cox model to study the effects of obesity on SCD in 
Japanese patients after myocardial infarction.  They provided a list of predicators such as 
age, gender, and blood pressure, which were used in this dissertation. 
Mohanty, Sahoo, Biswal, and Sabut (2018) provided a process to detect and 
classify ventricular tachycardia (VT) and ventricular fibrillation (VF) arrhythmias (two 
leading causes of SCD) using time-frequency domain features of processed ECG signals.  
They used support vector machine (SVM) and C4.5 for classification of selected features, 
where the latter had a better performance with 90.97% sensitivity, 97.86% specificity, 
and 97.02% accuracy.  The results of this paper were used for comparison with the results 
of the current dissertation. 
Su, Xia, Cao, and Gao (2018) provided a list of predictors.  They stated that 
premature ventricular contractions (PVCs) can lead to ventricular tachycardia (VT), 
which in turn can lead to ventricular fibrillation (VF) and SCD.  They assessed the 
cardiac characteristics and risk prediction in PVC patients with or without VT.  They 
concluded that PVC couplets (two consecutive premature ventricular contractions) is the 
highest risk factor for the development of VT in patients with frequent PVC.  Other risk 
factors included blood potassium, LVEF, extensive PVC burden (amounts of abnormal 




Ayesta et al. (2018) suggested that a combination of clinical, biochemical, 
echocardiographic, and electrical parameters is better than a single risk marker to best 
predict SCD in elderly patients with heart failure.  They provided a general survey on risk 
predictors, which influenced the choice of the ones used in this dissertation. 
Ng, Mistry, Li, Schlindwein, and Nicolson (2018) developed two ECG markers as 
predictors of ventricular arrhythmias and SCD.  They applied them as part of an under-
development tool (LifeMap) for SCD risk stratification.   
Kakimoto, Tanaka, Hayashi, Yokoyama, and Osawa (2018) studied the changes 
in miRNA expression from subjects who suffered SCD with cardiac hypertrophy (SCH).  
They compared cardiac tissues that were sampled at autopsy from SCH patients, 
compensated cardiac hypertrophy (CCH) subjects who died from causes other than heart 
failure, and control cases that were free from both cardiac hypertrophy and heart failure.  
They concluded that miR-221 had the most increase in SCH patients, hence established 
the relation between miR-221 levels and SCH patients. 
Rosset et al. (2018) asserted that arrhythmic drugs have no impact on preventing 
SCD.  Their findings are in line with the SCD-HeFT study.  They also provided 
justification to use amiodarone patients in this dissertation. 
Thomsen, Nielsen, Aarup, Bisgaard, and Pedersen (2018) attempted to establish 
links between chronic kidney disease (CKD) and sudden cardiac death.  Their research 
highlighted the effect of kidney diseases and QRS duration as predictors of SCD. 
Li et al. (2018) aimed to characterize the expression patterns of miRNAs in 




develop into heart failure and can cause SCD.  They included a list of clinical data such 
as age, gender, and blood pressure, which were used in this dissertation.  
Özyılmaz, Satılmışoğlu, Gül, Uyarel, and Serdar (2018) provided a list of features 
such as age, gender, NYHA class, creatinine, uric acid, and galectin-3 level.  They 
obtained a risk score for SCD using Cox model at 5 years-time. 
Ebrahimzadeh, Fayaz, Ahmadi, and Dolatabad (2018) produced two models to 
predict SCD within 4 minutes of its occurrence.  They used MLP and KNN classifiers 
that delivered an accuracy of 83.96% for the first and 81.49% for the second.  This 
research was used for comparison with the current dissertation. 
Ensemble Classifiers 
The idea behind ensemble classifiers stems from the human nature of seeking 
multiple expert advice when making important decisions, instead of trusting a single 
opinion (Harrington, 2012).  Based on empirical observations and specific machine 
learning applications, a given learning algorithm can outperform all others for a specific 
problem or for a specific subset of the input data, but not on the overall problem domain 
(Valentini & Masulli, 2002). 
Ensemble classifiers enhance the accuracy and the reliability of the overall 
inductive learning system because the overall system can recover if some base learners 
fail (Valentini & Masulli, 2002).  Dietterich (2002) described the supervised machine 
learning setting as one where each data point consists of a vector of features x, a class 
label y, and an underlying function f, where y = f(x) for each data point (x, y).  The 
machine learning algorithm searches through a space of possible functions, or 




f (Dietterich, 2002).  Ensemble classifiers help resolve three main problems that are 
experienced by learning algorithms that output only a single hypothesis (Dietterich, 
2002).  These are: 1) a statistical problem, when the learning algorithm is searching a 
space of hypotheses that is too large for the amount of training data; 2) a computational 
problem, when the learning algorithm cannot guarantee to find the best hypothesis within 
the hypothesis space; and 3) a representational problem, when the hypothesis space does 
not contain any hypothesis that is a good approximation to the true function f (Dietterich, 
2002).  A simple vote of all equally-good classifiers can reduce the risk of the statistical 
problem (Dietterich, 2002).  A weighted combination of several different local minima 
can reduce the risk of choosing the wrong local minimum to output, and hence handle the 
computational problem (Dietterich, 2002).  For the representational problem, a weighted 
sum of hypotheses can expand the space of functions that can be represented and hence 
forming a more accurate approximation to f (Dietterich, 2002). 
Ensemble classifiers can be divided into two distinct groups: non-generative 
ensembles and generative ensembles (Abad, Zare-Mirakabad, & Rezaeian, 2014; 
Valentini & Masulli, 2002).  The two types are briefly described below: 
Non-generative ensembles   
Non-generative ensemble methods attempt to combine a set of base learners 
(Valentini & Masulli, 2002).  They do not actively generate new base learners but try to 
combine a set of existing base classifiers in a suitable way (Valentini & Masulli, 2002).  
They are divided into ensemble fusion and ensemble selection methods (Abad et al., 
2014).  Ensemble fusion methods combine the outputs of the base classifiers, while 




base learners (Abad et al., 2014).  The most popular ensemble fusion method is expressed 
by majority voting ensembles (Abad et al., 2014).  Other techniques include Naïve-Bayes 
decision rule, Behavior-Knowledge Space (BKS) method and multiple operators such as 
Minimum, Maximum, Average, Product and Ordered Weight (Abad et al., 2014).  
Ensemble selection methods identify the best base classifiers among base learners where 
the output of the ensemble is equal to the output of the best classifier (Abad et al., 2014). 
Generative ensembles   
Generative ensemble methods generate sets of base learners acting on the base 
learning algorithm or on the structure of the data set and try to actively improve diversity 
and accuracy of the base learners (Valentini & Masulli, 2002).  They do so by either 
modifying the structure and the characteristics of the available input data, manipulating 
the aggregation of the classes, selecting base learners specialized for a specific input 
region, selecting a proper set of base learners, evaluating the performance and the 
characteristics of the component base learners or randomly modifying the base learning 
algorithm (Valentini & Masulli, 2002). 
Combining methods of ensemble classifiers   
Combining methods are used to improve a weak classifier (Skurichina & Duin, 
2002).  Weak classifiers refer to badly performing classifiers, unstable classifiers, 
classifiers of a low complexity, or classifiers that depend on certain assumed models that 
are not always true (Skurichina & Duin, 2002).  The below methods work well on 
homogenous ensembles and attempt to generate diversity by sampling from or assigning 
weights to training sets (Whalen & Pandey, 2013).  They generally use a single type of 




where base classifiers produce different errors (Valentini & Masulli, 2002).  Diversity is 
key to the overall performance of ensemble classifiers (Whalen & Pandey, 2013). 
Bagging.  Breiman (1996) introduced bagging, which is a technique where the 
data is taken from the original dataset S times, resulting in creating S new datasets 
(Harrington, 2012).  Each of these new datasets are of the same size as the original 
(Harrington, 2012).  Each dataset is built by randomly selecting an example from the 
original dataset (Harrington, 2012).  The same example can be selected more than once 
(which is referred to as selection with replacement) resulting in repeated values in the 
new dataset and some values from the original dataset not being present in the new 
dataset (Harrington, 2012).  The learning algorithm is then individually applied to the 
new set (Harrington, 2012).  To classify a new piece of data, the S classifiers are applied 
to the new piece of data and classification is performed through a majority vote 
(Harrington, 2012). 
Boosting.  Freund and Schapire (1996) introduced boosting, in which the different 
classifiers are trained sequentially (Harrington, 2012).  Each new classifier is trained 
based on the performance of those already trained (Harrington, 2012).  The focus of 
boosting is on data that was previously misclassified by previous classifiers (Harrington, 
2012).  The output is calculated from a weighted sum of all classifiers (Harrington, 
2012).  The weights are based on how successful the classifier was in the previous 
iteration (Harrington, 2012).  Initially, all objects have equal weights, and the first 
classifier is constructed on this data set (Skurichina & Duin, 2002).  Then, weights are 
changed according to the performance of the classifier (Skurichina & Duin, 2002).  




reweighted training set (Skurichina & Duin, 2002).  AdaBoost is a popular boosting 
algorithm (Bauer & Kohavi, 1998; Ghavidel, Yazdani, & Analoui, 2013; Harrington, 
2012). 
Random subspace.  Ho (1998)  introduced the random subspace method.  In this 
technique, classifiers are constructed in random subspaces of the data feature space and 
are usually combined by simple majority voting in the final decision rule (Skurichina & 
Duin, 2002).  Another approach is to build the ensemble from the predictions of a wide 
variety of heterogeneous classifiers such as decision trees, support vector machines, and 
neural networks as base classifiers (Whalen & Pandey, 2013). 
Stacking.  Stacking constructs a higher-level predictive model over the 
predictions of base classifiers (Whalen & Pandey, 2013).   
Ensemble selection.  Ensemble selection uses an incremental strategy to select 
base predictors for the ensemble while balancing diversity and performance (Whalen & 
Pandey, 2013). 
Ensemble classifiers usage 
Johansson et al. (2008) showed that by using a class-specific reliability measure 
instead of one based on the overall accuracy, the predictive performance of applying 
combination rules in an evidential framework can be improved.  Ramos-Jimenez, del 
Campo-Avila, and Morales-Bueno (2009) presented a two-layers system where the first 
layer consisted of an ensemble classifier of 10 decision trees, and the second layer was a 
single classifier that was induced using the examples that were not unanimously voted by 
the ensemble.  In addition, the examples that reached the second layer incorporated 




by each base classifier in the ensemble and the class estimated by the ensemble itself.  
The idea was that second level can provide more informed classification, and hence 
improve the overall accuracy of the system.  Bagheri and Gao (2012) proposed a 
classifier selection method based on the divide-and-conquer technique.  The idea was to 
break down the classification problem into simpler binary classification problems.  A 
first-guesser classifier was used to find the two most probable classes.  Based on those 
two classes, one of the previously trained classes was called to resolve the binary 
classification problem.  The proposed method slightly improved the overall classification 
accuracy but significantly lowered the execution time compared with existing ensemble 
classification methods.  Verma and Rahman (2012) presented a cluster-oriented ensemble 
classifier (COEC) that was based on learning of cluster boundaries by the base classifiers.  
The proposed ensemble classifier clusters classified data into multiple clusters, learned 
the decision boundaries between clusters using a set of base classifiers, and combined the 
cluster decisions produced by the base classifiers into a class decision by a fusion 
classifier.  The proposed system was evaluated on benchmark datasets from UCI machine 
learning repository.  Results showed that: 1) Homogeneous clustering performs 
significantly better than heterogeneous clustering with COEC; 2) The proposed COEC 
performs significantly better than its base counterparts; 3) Fusion classifier performs 
significantly better than algebraic fusion with COEC; 4) COEC outperforms classical 
ensemble classifiers namely bagging, boosting, and random subspace method 
significantly on benchmark data sets.  Gupta, Audhkhasi, and Narayanan (2014) 
addressed the limitations of training algorithms.  They defined such limitations as 




independently perform classifier training and feature selection.  They defined feature 
subset selection and training of diverse classification as an optimization problem and 
proposed a greedy algorithm to resolve this problem.  The algorithm performed joint 
optimization to determine class boundaries and the feature set for each classifier in the 
ensemble.  The authors introduced a loss function that introduced data-driven diversity.  
They sequentially optimized the loss function for each classifier in the ensemble.  They 
used an oracle fusion function and an equal weighting function to obtain the final 
decision from the ensemble.  They presented the results on several datasets and observed 
that not only the algorithm trained better classifier ensembles, but also filtered out 
features unrelated to class assignments.  Yu, Li, Liu, and Han (2015) identified some of 
the limitations of traditional random subspace-based ensemble approaches (RSCE) as 
viewing the same importance for the base classifiers trained in different subspaces, and 
not considering how to find the optimal random subspace set.  They designed a general 
hybrid adaptive ensemble learning framework (HAEL) that addressed the limitations of 
RSCE.  HAEL consisted of two adaptive processes: base classifier competition and 
classifier ensemble interaction, to adjust the weights of the base classifiers in each 
ensemble and to explore the optimal random subspace set simultaneously.  Their 
proposed framework was characterized with the following two properties: 1) the adoption 
of a base classifier competition adaptive process (BCCAP) to adjust the weights of the 
classifiers in the ensemble and 2) the adoption of a classifier ensemble interaction 







The Cox hazard model has been used extensively in the medical field.  The 
selected research papers below demonstrate the usage and importance of the Cox hazard 
model. 
Van Dijk, Steyerberg, Stenning, Dusseldorp, and Habbema (2004) used the Cox 
regression model to examine the extent of any loss in discrimination within the 
classification provided by the International Germ Cell Consensus (IGCC).  The latter 
identified a 3-level prognosis groups (good, intermediate and poor) among patients with 
metastatic nonseminomatous germ cell tumors (NSGCT), based on some risk factors.  
The SCD-HeFT trial used the Cox model to test the interactions between the 
NYHA class and the type of treatment (ICD, amiodarone, or placebo), and also between 
the cause of CHF and the treatment (Bardy  et al., 2005).  This paper influenced the use 
of the SCD-HeFT data in this dissertation, because it demonstrated that the Cox model 
was previously applied to it. 
Zhao (2005) extended the Cox model to enable it to consider familial correlation 
between family members.  He applied his framework to data from the Collaborative 
Study on the Genetics of Alcoholism.  He also used R for his data analysis.  
Bellera et al. (2010)  emphasized the importance of the assumption that the Cox 
model relies on the proportional hazards (PH).  This meant that the factors investigated 
have a constant impact on the hazard over time.  They argued that checking the 
proportionality of hazards should be an integral part of a survival analysis based on a Cox 




cancer with surgery.  With a median follow-up of 14 years, they showed that 
conventional Cox model did not catch all the effective factors. 
Royston and Altman (2013) described statistical approaches to external validation 
of a published Cox model and applied their methods to two datasets for breast cancer, 
where one was a derivation dataset, and the other was a validation dataset.  They 
concluded that their methods are applicable to a wide range of prognostic studies. 
Darwiche and Mukherjee (2018) used the Cox model to obtain a score 20 hours 
before septic shock occurrence, then added the score to features and applied random 
forest ensemble to classify patients.  The paper demonstrated the use of Cox model as a 










The aim of this dissertation was to build an ensemble classifier to predict SCD 
among NYHA class II and class III heart failure patients, within 180 days from admission 
point.  The main tasks involved data collection, features selection, data cleanup and 
preparation, prediction model, validation process, and results evaluation.  
Data Collection 
Data was obtained from the Sudden Cardiac Death in Heart Failure Trial (SCD-
HeFT) (Bardy  et al., 2005).  It was made available by the National Heart, Lung and 
Blood Institute (NHLBI).  The trial involved a recruitment period from September, 1997 
to July, 2001, and a follow-up period until October, 2003 (Bardy  et al., 2005). 
The aim of SCD-HeFT was to determine whether amiodarone, a medication that is 
used to treat and prevent certain types of serious, life-threatening ventricular arrhythmias 
(MedlinePlus, 2017a), or the implantable cardioverter-defibrillator (ICD) would decrease 
the overall mortality in patients with coronary artery disease or nonischemic 
cardiomyopathy who are in heart failure NYHA class II or III and have a left ventricular 
ejection fraction (LVEF) ≤35% (Klein, Auricchio, Reek, & Geller, 1999).  Ejection 
fraction is a measurement of the percentage of blood leaving the heart each time it 




usually measured only in the left ventricle ("Ejection fraction: What does it measure?," 
2018). 
To be included in that trial, patients must have been 18 years of age or older, must 
have had heart failure NYHA class II or III for at least 3 months prior to enrollment, must 
have had LVEF ≤35%, must have had their CHF treated with a vasodilator, a medication 
that opens (dilates) blood vessels (Mayo Clinic Staff, 2016), and have been requested to 
have a coronary angiogram to detect possible coronary disease or to determine the nature 
of their disease (Klein et al., 1999). 
Exclusion criteria from the trial consisted of: 1) patients that showed no 
symptoms of heart failure (asymptomatic patients); 2) patients who have survived a 
cardiac arrest or who have experienced sustained ventricular tachycardia (VT), except 
during the acute phase of myocardial infarction; 3) patients who were judged to have high 
probability of death from noncardiac causes within 12 months; 4) patients in heart failure 
due to causes other than dilated cardiomyopathy or coronary artery disease; 5) patients 
who were taking amiodarone or who had a contraindication for amiodarone, where a 
contraindication is a specific situation in which a drug, procedure, or surgery should not 
be used because it may be harmful to the person (MedlinePlus, 2017b); 6) patients who 
have had an unexplained syncope within the 5 years prior to the trial, where a syncope is 
a temporary loss of consciousness usually related to insufficient blood flow to the brain; 
(American Heart Association, 2017) and, 7) patients who were expected to have a heart 
transplant (Klein et al., 1999). 
SCD-HeFT was a randomized trial where patients were randomly assigned to one 




heart failure treatment and placebo (Klein et al., 1999).  A placebo is an inert or 
innocuous substance used especially in controlled experiments testing the efficacy of 
another substance ("Merriam-Webster Medical Dictionary," 2017).  The second group 
combined conventional heart failure treatment and amiodarone (Klein et al., 1999).  The 
third group employed conventional heart failure therapy and a single-lead pectoral ICD 
that was inserted through an outpatient procedure (Klein et al., 1999).  Placebo and 
amiodarone were delivered in a double-blind fashion to avoid treatment bias in favor of 
amiodarone (Klein et al., 1999).  A double-blind fashion is an experimental procedure in 
which neither the subjects nor the experimenters know which subjects are in the test and 
control groups during the actual course of the experiments ("Merriam-Webster Medical 
Dictionary," 2017). 
There were 2,521 patients enrolled in the SCD-HeFT study, with 847 patients 
assigned to the placebo group, 845 patients assigned to the amiodarone group, and 829 
patients assigned to the ICD group (Bardy  et al., 2005).  Table 1 demonstrates the 
patients’ distribution over the three groups of the study, along with the death count in 
each group. 
Table 1.   
 
Patients Population 
Group  Total Patients Total Deaths Total SCDs 
Placebo 847 244 88 
Amiodarone 845 240 72 
ICD 829 182 34 





An ICD is a device that is placed in the patient's chest to reduce the risk of SCD 
by detecting and stopping abnormal heartbeats through electrical pulses to regulate the 
patient’s heartbeat (Mayo Clinic, 2018b).  Therefore, it has a direct impact on the SCD 
outcome and patients using it were excluded from this dissertation.  Given that 
amiodarone had no statistical significance on survival (Bardy  et al., 2005), this group 
was included in the dissertation.  Thus, the total initial population for this dissertation was 
1,692 (Placebo and Amiodarone) subjects, with a total of 160 SCD cases (Placebo and 
Amiodarone). 
Features Selection 
The features shown in table 2 existed in the available SCD-HeFT data (Bardy  et 
al., 2005), and were considered based on the literature (Adabag et al., 2014; Ayesta et al., 
2018; Deo et al., 2016; Desai et al., 2018; Eranti et al., 2016; Fan et al., 2014; Goldstein, 
Chang, Mitani, Assimes, & Winkelmayer, 2014; Huikuri et al., 2003; Kubik et al., 2018; 
Kurbanov et al., 2015; Li et al., 2018; Liew, 2011; O'Mahony et al., 2014; Pascual-Figal 
et al., 2009; Piccini et al., 2010; Rai & Agrawal, 2016; Shastri et al., 2012; Shiga et al., 
2018; Stecker & Chugh, 2011; Thomsen et al., 2018; Weeks et al., 2016; Wellens et al., 
2014).  There were 31 features listed in table 2 which were a subset of the 96 features 
used in the SCD-HeFT study.  This was a preliminary list and further research resulted in 
updating the features list, as explained in later sections. 
Table 2. 
  
Potential Features to Be Used for Prediction 
Feature Name Type Description Data Type Allowable 
Values 
Age Demographic Patient’s age Numeric 18 – 100  
Gender Demographic Patient’s 
gender 
Numeric 1 – Male 











Weight Vital Patient’s 
weight 










Numeric 30 – 140  
Heart rate Vital Self-
explanatory 
Numeric 30 – 156  
History of SCD History Family history 
of SCD 
Numeric 0 – No  
1 – Yes  




Numeric 0 – No  
1 – Yes 




Numeric 1 – 100  
Diabetes Diagnosis Patient has 
diabetes 
Numeric 0 – No  
1 – Yes 





Numeric 3 – 300  




Numeric 1 – I  
2 – II  
3 – III  
4 – IV  




Numeric 0 – No  
1 – Yes 
Hypertension Diagnosis Patient is 
diagnosed with 
hypertension 
Numeric 0 – No  







Numeric 0 – No  








Numeric 0 – No  
1 – Yes  
CABG History Coronary 
Artery Bypass 
Graft 
Numeric 0 – No  
1 – Yes  
Alchool abuse History Self-
explanatory 
Numeric 0 – No  
1 – Yes  
Smoking History Self-
explanatory 
Numeric 1 – Never  
2 – Current  
3 – Past  
Cocaine abuse History Self-
explanatory 
Numeric 0 – No  
1 – Yes 
Stroke History Patient 
suffered a 
stroke 
Numeric 0 – No  
1 – Yes 
Serum sodium Measurement Sodium 
measurement 





Numeric 2.0 – 7.0 
Serum magnesium Measurement Magnesium 
measurement 
Numeric 0.0 – 9.0 
Serum creatinine Measurement Creatinine 
measurement 
Numeric 0 – 566  
Aspirin Medication Patient is on 
aspirin 
Numeric 0 – No  
1 – Yes 
Beta-blocker Medication Patient is on 
beta-blocker 
Numeric 0 – No  
1 – Yes 
Statin Medication Patient is on 
statin 
Numeric 0 – No  








Numeric 0 – No  
1 – Yes 
QT Interval Measurement Self-
explanatory 
Numeric 308.00 – 
604.00  
 
SCD-HeFT was intended to evaluate the theory that amiodarone or a 
conservatively programmed shock-only, single-lead ICD would decrease the risk of death 
from any cause in patients with mild-to-moderate heart failure (Bardy  et al., 2005).  It 




study was used for SCD prediction, which was the goal of this dissertation.  Therefore, 
not all SCD-HeFT features were used by this dissertation.  While the features in table 2 
were part of the 96 starting features of the SCD-HeFT, the difference was due to the 
following reasons: 
• Some features were specific to SCD-HeFT study and were not mentioned in 
other references. 
• SCD-HeFT expanded some features, which was not useful for this 
dissertation.  For example, SCD-HeFT contained age, age65, and age75 
features to describe the patient’s age.  Only the age feature was used in this 
dissertation. 
Some SCD-HeFT features were ICD-related, and ICD patients were excluded 
from this dissertation.   
Data Cleanup and Preparation 
This section refers to placing the data in a format that can be used by the 
prediction model.  Due to the Health Insurance Portability and Accountability Act 
(HIPAA) rules, patients in the SCD-HeFT database are de-identified.  In the SCD-HeFT 
database, patients are uniquely identified by a patient id code (PID).  The start time of 
any patient in the study is considered time t = 0, and all dates of vitals and lab works are 
calculated as the number of days/months from the start date.  
The dataset consisted of multiple records per patient, one at each timestamp.  
Each single record consisted of the patient id, the start of the time bucket, the end of the 




to encode time-dependents features (Therneau, Crowson, & Atkinson, 2013).  This means 
that for example at day 7, SBP is 130 and DBP is 70 (Therneau et al., 2013).   
Taking just the systolic blood pressure (SBP) and diastolic blood pressure (DBP) 
features as examples, table 3 shows the records for a patient who completed the trial 
without suffering from SCD. 
Table 3.   
 
A sample patient (PID SCD_HEFT0001) with 2 sample features who did not suffer SCD 
PID StartTime EndTime SBP DBP SCD 
SCD_HEFT0001 0 7 130 70 0 
SCD_HEFT0001 7 34 100 70 0 
SCD_HEFT0001 34 129 128 64 0 
SCD_HEFT0001 129 183 140 78 0 
SCD_HEFT0001 183 323 142 78 0 
SCD_HEFT0001 323 432 150 74 0 
SCD_HEFT0001 432 569 150 82 0 
SCD_HEFT0001 569 702 120 82 0 
SCD_HEFT0001 702 919 140 80 0 
SCD_HEFT0001 919 1063 128 80 0 
SCD_HEFT0001 1063 1281 138 78 0 
SCD_HEFT0001 1281 1541 108 64 0 
 
Table 4 demonstrates a patient who suffered from SCD prior to completing the 
trial.  The last row consists of the last known vital signs that were recorded before death. 
Table 4.  
 
A sample patient (PID SCD_HEFT0023) with 2 sample features who suffered SCD 
PID StartTime EndTime SBP DBP SCD 
SCD_HEFT0023 0 7 130 80 0 
SCD_HEFT0023 7 33 122 78 0 
SCD_HEFT0023 33 68 120 62 0 
SCD_HEFT0023 68 223 130 62 0 
SCD_HEFT0023 223 292 140 75 0 
SCD_HEFT0023 292 398 130 82 0 




SCD_HEFT0023 525 616 120 80 0 
SCD_HEFT0023 616 732 120 80 1 
 
The problem of missing data is common in medical trials (Dziura, Post, Zhao, Fu, 
& Peduzzi, 2013; Kenward, 2013).  Data can be incorrectly recorded or not recorded at 
all.  These were handled via simple imputation techniques, such as last observation 
carried forward  (LOCF), and last observation carried backward (LOCB) (Dziura et al., 
2013).  A subject was eliminated from the dataset if any of its features could not be 
imputed (had no readings for that feature). 
In addition, due to the low number of positive SCD cases in the dataset, random 
sampling techniques were used.  Undersampling was applied to randomly eliminate 
majority class subjects (class = 0), while oversampling was used to randomly replicate 
minority class subjects (class = 1) (Kotsiantis et al., 2006).  
For prediction purposes, the dataset was randomly partitioned into 80% training 
set and 20% testing set.  The training set was equally divided into k partitions with k = 5 
to use the k-fold cross-validation technique. 
Performance Measures 
To assess the performance of the prediction model, the following metrics were 
calculated: 
• True Positive (TP):  The patient suffers an SCD and the system correctly 
predicts SCD. 
• False Positive (FP):  The patient is normal, and the system incorrectly 
identifies him as an SCD case. 
• True Negative (TN):  The patient is normal, and the system correctly 




• False Negative (FN):  The patient had an SCD and the system incorrectly 
identifies him as normal. 
• Confusion Matrix:  It demonstrates a comparison between predicted and 
actual outcome (Lantz, 2015).  Table 5 shows the confusion matrix.  
Table 5.  
 
Confusion matrix 
 Actual True Actual False 
Predicted True TP FP 
Predicted False FN TN 
 
• Accuracy:  It is the ratio of the total number of correct assessment to the total 
number of evaluations (Sheela & Vanitha, 2014; Vanitha et al., 2014). 
𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =  
(𝑇𝑃 + 𝑇𝑁)
(𝑇𝑃 + 𝐹𝑃 + 𝑇𝑁 + 𝐹𝑁)
 
• Sensitivity:  It refers to the ability of the system to correctly identify patients 
with cardiac arrest (Parikh, Mathai, Parikh, Sekhar, & Thomas, 2008; Sheela 
& Vanitha, 2014; Vanitha et al., 2014). 




• Specificity:  It refers to the ability of the system to correctly identify normal 
cases (Parikh et al., 2008; Sheela & Vanitha, 2014; Vanitha et al., 2014). 




• Positive Predictive Value (PPV):  It refers to the probability that the patient is 
having a cardiac arrest when the system identifies her as one having a cardiac 








• Negative Predictive Value (NPV):  It refers to the probability that the patient 
is not having a cardiac arrest when the system identifies her as one not having 
a cardiac arrest (normal)  (Parikh et al., 2008; Sheela & Vanitha, 2014; 
Vanitha et al., 2014). 




• Receiver Operating Characteristic (ROC) curve:  It is used to examine the 
trade-off between the detection of true positives, while avoiding the false 
positives (Lantz, 2015).  The Y-axis designates the true positive rate 
(sensitivity), while the X-axis designates false positive rate (1 – specificity).  
To summarize how well a clssifier performs, the area under the ROC curve 
(AUC) is used (Wang et al., 2015).  Wang et al. (2015) define the AUC as the 
probability that the decision value assigned to a randomly-drawn positive 
sample is greater than the value assigned to a randomly-drawn negative 
sample.  The AUC ranges from 0.5 to 1, with larger values representing higher 
system performance (Wang et al., 2015).  
• F1 Score: It is a measure of a test’s accuracy through the use of the harmonic 
mean between sensitivity and PPV  (Forte, 2015; Lantz, 2015). 














The outcome of this dissertation was an SCD prediction model.  This was done by 
using the Cox proportional hazard model to add a hazard score.  The Cox proportional 
hazard model is the most widely used method for survival analysis (Fox, 2002).  The 
term survival analysis refers to examining and modeling the elapsed time for events to 
occur (Fox, 2002).  The Cox proportional hazard model relies on the assumption of the 
proportionality of the hazards, where the investigated factors have a constant impact on 
the hazard over time (Bellera et al., 2010).  The Cox proportional hazard model is defined 
with the below equation: 
ℎ(𝑡) =  ℎ0(𝑡) × 𝑒
∑ 𝛽𝑖 × 𝑋𝑖
𝑛
𝑖=1  
The value h0(t) is referred to as the baseline hazard rate (Bellera et al., 2010; Fox, 
2002; Zhou, 2001).  It is a non-negative function of time that constitutes the time-
dependent part of the hazard (Bellera et al., 2010).  It is the hazard rate when the values 
of all features are zeros (Bellera et al., 2010).  βi is the regression coefficient which gives 
the proportional change that can be expected, related to the change in the explanatory 
variables (Walters, 2009).  Xi is the i
th feature value from the features’ list and n is the 
total number of features.  The regression coefficients are calculated using appropriate 
computer programs (Walters, 2009).  This dissertation used the survival library in R.  The 
model is constructed using the coxph() function where the coefficients were calculated.   
The Hazard Ratio (HR) for each patient was calculated based on the coefficients 
obtained from fitting the Cox hazard model multiplied by the value of the features at the 
instant of time desired (180 days and 365 days before the occurrence of SCD in our case), 







=  𝑒∑ 𝛽𝑖 × 𝑥𝑖
𝑛
𝑖=1  
The Extra-Trees algorithm (Geurts, Ernst, & Wehenkel, 2006) was used as an 
ensemble classifier to predict whether a patient will suffer an SCD at a prediction point.  
To enhance the accuracy of the model, we obtained the HR at prediction point, then 
added it to the dataset as a feature.  The algorithm built an ensemble of unpruned trees 
(decision or regression) using the standard top-down procedure (Geurts et al., 2006).  It 
differs from other tree-based ensemble methods in that it splits nodes by choosing cut-
points fully at random, and that it uses the whole learning sample, not just a bootstrap 
replica, to grow the trees (Geurts et al., 2006).  The explicit randomization of the cut-
point and attribute, along with the ensemble averaging is aimed at reducing the variance 
in a stronger way than the randomization schemes used by other methods, while the 
usage of the full original learning sample is intended to minimize bias (Geurts et al., 
2006).  Using the Extra-Trees algorithm, the model with the dataset enhanced by Cox 
was trained, validated, and tested. 
Model Training   
With a Cox-enhanced training dataset supplied as input, the following steps were 
performed to train the model: 
1. Import the necessary libraries.  These include data handling, computations, 
and ensemble classifier libraries. 
2. Read the training data file. 
3. Pre-process training data, as necessary, to handle any unwanted characters 
in the file, or set categoral data as distinct numbers instead of strings. 




Model Validation   
The k-fold cross validation technique was used to validate the proposed prediction 
model.  A number of folds, k = 5 were chosen  (Beleites, Neugebauer, Bocklitz, Krafft, & 
Popp, 2013).  The Accuracy, Sensitivity, Specificity, F1 Score, and Area under ROC 
metrics were used at each iteration.  The mean and standard deviation (SD) were 
calculated to evaluate the overall performance of the system.  The measurements were 
used to compare the results of all iterations to verify consistency across the whole 
validation process.  Validation helped reduce bias and variance that might impact the 
parameters and performance of the predictive model (Beleites et al., 2013).  Besides, it 
helped prevent overfitting the training data (Refaeilzadeh, Tang, & Liu, 2009).  The k-
fold validation process works as follows: 
1. Divide the training set into k subsets, where the size of each subset is n/k 
(n = size of training set). 
2. For i = 1 to k 
a. Train each classifier of the ensemble using all folds but i. 
b. Test the ensemble using fold i. 
c. Compute performance metrics Accuracy, Sensitivity, Specificity, 
F1 Score, and Area under ROC, for the current iteration. 
3. Compute the mean and standard deviation of all iterations for each metric. 
Model Testing   
Using the Cox-enhanced test set, the following steps were performed to test the 
model at 6 months before SCD: 




2. Pre-process test data as necessary, to handle any unwanted characters in 
the file, or set categoral data as distinct numbers instead of strings. 
3. Predict the outcome using the trained ensemble. 
4. Calculate Accuracy, Sensitivity, Specificity, F1 Score, and Area under 
ROC.   
Model Comparison   
The proposed prediction model in this dissertation was compared against three 
SCD prediction models published in peer-reviewed journals.  The aim was to exceed the 
accuracy, the lead time, or both over the considered models.  The first model was 
developed by Devi et al. (2016), which was a KNN classifier that used the Normal Sinus 
Rhythm dataset and the SCD Holter database from Physionet, and predicted SCD one 
hour before its occurrence at 95% accuracy.  The second model was a C4.5 classification 
model developed by Mohanty et al. (2018), which utilized the CU Ventricular 
Tachyarrhythmia Database (CUDB) and MIT-BIH Malignant Ventricular Ectopy 
Database (VFDB) from Physionet, and achieved 90.97% sensitivity, 97.86% specificity, 
and 97.02% accuracy.  The third model was an MLP model developed by Ebrahimzadeh 
et al. (2018), which was based on the MIT-BIH Sudden Cardiac Death Holter and 
Normal Sinus Rhythm databases from Physionet, and achieved 83.96% accuracy for SCD 












The goal of this dissertation was to develop a prediction model to predict SCD 
180 days and 365 days before occurrence.  We used a combination of Cox hazard model 
and the ExtraTreesClassifier ensemble technique.  This chapter illustrates the results of 
the experiments we ran, along with the validation of the final model, and the comparison 
against the selected literature. 
Model Results 
We ran four experiments with the selected features.  First, we generated the 
training and test data files with selected features and valid subjects.  As previously stated, 
records containing features that had no measures could not be imputed, and had to be 
dropped.  Also, patients that did not follow the study guidelines and had their first follow-
up visit after the prediction point were dropped as well.  Second, we reviewed our 
features selection process.  Features that had no data in many records prevented the 
imputation and caused the majority of the records to be dropped.  Therefore, these 
features were excluded in the first place.  The used features were the ones that were 
statistically significant, were of medical importance (based on literature and on expert 
medical opinion), and were populated with data for the majority of the records.  The 




selection wrapper algorithm that uses Random Forest and  provides a variable importance 
measure (VIM) (Kursa & Rudnicki, 2010), which was used to guide the final feature 
selection.  Based on the above, the final set of selected features is shown in table 6. 
Table 6. 
 













Finally, to compensate for the low number of positive cases in the dataset, we 
applied oversampling and undersampling techniques.  We ran two variations of the test at 
180 days and at 365 days as prediction points.  These were as follows: 
• We used the selected features at prediction point and added an additional 
field called duration, which is the time elapsed between the last test and 
the current one.   
• We first obtained the Cox coefficients using the R survival library by 
fitting a Cox model on the entire training set, and then calculated the HR 
for both training and test sets at prediction point. 
• We used the selected features at prediction point and added Cox model 




180 Days with Cox 
The resulting files from fitting the Cox model and adding the HR as a feature 




Cox coefficients when running at 180 days 
 
The training set size was at 534 records while the test set size was at 133 records.  




Performance metrics – 180 days with Cox 
Accuracy Sensitivity Specificity F1 Score AUC 
0.9624 0.7500 0.9915 0.9607 0.8707 











Confusion matrix – 180 days with Cox 
 0 1 
0 116 1 
1 4 12 
 
 Figure 2 shows the outcome of the folds’ iterations, while figure 3 shows the 
overall outcome of the folds test. 
Figure 2. 
 




Overall Outcome of k-folds – 180 days with Cox 
 
180 Days without Cox 
We first read the training and test files at prediction point.  We then pre-processed 
the data then used it to train and test the ensemble classifier.  The training set size was at 
534 records while the test set size was at 133 records. Table 9 lists the performance 







Performance metrics – 180 days without Cox 
Accuracy Sensitivity Specificity F1 Score AUC 
0.9549 0.7500 0.9829 0.9536 0.8665 
 
Table 10. 
Confusion matrix – 180 days without Cox 
 0 1 
0 115 2 
1 4 12 
 
Figure 4 shows the outcome of the folds’ iterations, while figure 5 shows the 
overall outcome of the folds test. 
Figure 4. 
 












365 Days with Cox 
 The resulting files from fitting the Cox model and adding the HR as a feature 




Cox coefficients when running at 365 days 
 
The training set size was at 464 records while the test set size was at 116 records.  
Table 11 lists the performance metrics of this test, while table 12 illustrates the confusion 
matrix. 
Table 11.  
 
Performance metrics – 365 days with Cox 
Accuracy Sensitivity Specificity F1 Score AUC 












Confusion matrix – 365 days with Cox 
 0 1 
0 88 4 
1 4 20 
 
Figure 7 shows the outcome of the folds’ iterations, while figure 8 shows the 
overall outcome of the folds test. 
Figure 7. 
 






Overall Outcome of k-folds – 365 days with Cox 
 
365 Days without Cox 
We first read the training and test files at prediction point.  We then pre-processed 
the data then used it to train and test the ensemble classifier.  The training set size was at 
464 records while the test set size was at 116 records. Table 13 lists the performance 






Performance metrics – 365 days without Cox 
Accuracy Sensitivity Specificity F1 Score AUC 




Confusion matrix – 365 days without Cox 
 0 1 
0 90 2 
1 4 20 
 
Figure 9 shows the outcome of the folds’ iterations, while figure 10 shows the 
overall outcome of the folds test. 
Figure 9. 
 












This chapter provided the detailed results of test and validation of the SCD 
prediction model.   Four tests were conducted for 180 days and 365 days, with and 
without Cox HR.  The model was validated using a k-fold cross validation technique with 
k = 5.  The assessment used the accuracy, sensitivity, specificity, F1 score, and AUC to 
evaluate the model’s performance. 
The 180-days with Cox yielded the best accuracy at 0.9624, the best specificity at 
0.9915, and the best F1 score at 0.9607.  The best AUC was obtained from the 365-days 
without Cox, at 0.9058.  Cox had no effect on sensitivity for both 180-days and 365-days.  
It was at 0.7500 and 0.8333 respectively.  
We compared the model with three established ones.  The first model was 
developed by Devi et al. (2016), which is a KNN classifier that used the Normal Sinus 
Rhythm dataset and the SCD Holter database from Physionet, and predicted SCD one 
hour before its occurrence at 95% accuracy.  The second model was a C4.5 classification 
model developed by Mohanty et al. (2018), which utilized the CU Ventricular 
Tachyarrhythmia Database (CUDB) and MIT-BIH Malignant Ventricular Ectopy 
Database (VFDB) from Physionet, and achieved 90.97% sensitivity, 97.86% specificity, 
and 97.02% accuracy.  This paper used the Physionet normal sinus rhythm (NSR), the 
MIT-BIH Malignant Ventricular Ectopy, and the CU Ventricular Tachyarrhythmia 
Database.  These are research databases and are characterized by the low number of 
subjects (18, 22, and 35 respectively).  In addition, the research did not indicate any 
prediction time.  Even after sampling, we used 676 subjects for 180-days prediction 




developed by Ebrahimzadeh et al. (2018), which was based on the MIT-BIH Sudden 
Cardiac Death Holter and Normal Sinus Rhythm databases from Physionet, and achieved 
83.96% accuracy for SCD prediction within 4 minutes of its occurrence.   
Our system outperformed the other three systems in terms of lead time which 
compensates for the small difference in accuracy with respect to the work present by 











This dissertation presented an ensemble model to predict SCD within 180 and 365 
days.  The model blended the strengths of the Cox Hazard Model with the power of the 
ExtraTreesClassifier ensemble.  This chapter concludes the dissertation and highlights the 
implications of the current work in the medical field, particularly in the area of SCD 
prediction.  It then provides recommendations for future work and ends with a summary 
of the work. 
Conclusions 
The focus of this study was to answer the following question: 
RQ 
Can one develop an ensemble model to predict SCD with acceptable accuracy and 
practical lead time? 
The above question was answered through the development of an SCD prediction 
system that can predict the condition both at 6 months to one year before its occurrence.  
The system outperformed the work it is compared to in terms of lead time, and was very 
competitive in terms of accuracy, sensitivity, and specificity.  The performance of the 























Cox 0.9624 0.7500 0.9916 0.9607 0.8707 180 
days 
No Cox 0.9549 0.7500 0.9829 0.9536 0.8665 180 
days 
Cox 0.9310 0.8333 0.9565 0.9310 0.8949 365 
days 
No Cox 0.9438 0.8333 0.9783 0.9474 0.9058 365 
days 
 (Devi et al., 
2016) 
0.9500 N/A N/A N/A N/A 1 
hour 
 (Mohanty et 
al., 2018) 
0.9702 0.9097 0.9786 N/A N/A N/A 
 (Ebrahimzadeh 
et al., 2018) 
0.8396 N/A N/A N/A N/A 4 
min. 
Implications 
Successful prediction of SCD can have huge impact on the medical system.  SCD 
is generally treated with ICD, which is expensive and sometimes dangerous to implant, 
especially with patients with heart condition.  Being able to predict it in advance can 
enable doctors to implant the device before it is too late and while the patient is in a good 
condition to sustain the procedure. 
On the other hand, ICDs will only be used with patients that actually need them.  
This is particularly important in under-privileged areas where medical supplies are 
scarce.  In addition, it will help drive the insurance costs down, since the ICD implants 
will be done on an as-needed basis not as a precautionary measure.   
The work presented in this dissertation contributed to the current state of SCD 
prediction.  The tool is able to predict the potential SCD with a comfortable lead time, 





As previously discussed, the SCD-HeFT data that was used in the current work 
was characterized by the low number of positive cases with respect to the entire dataset.  
For better validation, it is recommended to apply other datasets to the prediction model. 
In addition, the current model can be applied in other medical areas, or even non-
medical areas that incorporate time variant data, such as weather or agriculture.  Finally, 
other ensemble mechanisms can be applied to see if that can outperform the Extra-Trees 
Classifier that was used in the current work. 
Summary 
In this dissertation, we developed an SCD prediction system for patients with 
NYHA class II and class III heart failure, using Cox hazard model and the ExtraTrees 
ensemble classifier. Data from the Sudden Cardiac Death in Heart Failure Trial (SCD-
HeFT) (Bardy  et al., 2005).  We started with 1692 subjects, and due to sampling and 
exclusions, ended up using 676 subjects for 180-days prediction point, and 580 subjects 
for 365-days prediction point. The highest accuracy we achieved was 0.9624 at 180-days 
with Cox.  The best specificity was 0.9915, and the best F1 score was 0.9607, at the same 
time.  The best AUC was obtained from the 365-days without Cox, at 0.9058.  Cox had 
no effect on sensitivity, which was at 0.7500 and 0.8333 for 180-days and 365-days 
respectively.     
In conclusion, the current model was able to predict SCD at lead times up to a 
year, while maintaining a high-level of prediction accuracy, thus adding a contribution to 





Abad, S. K. J., Zare-Mirakabad, M. R., & Rezaeian, M. (2014, 29-30 Oct. 2014). An 
approach for classifying large dataset using ensemble classifiers. Paper presented 
at the Computer and Knowledge Engineering (ICCKE), 2014 4th International 
eConference on. 
Acharya, U. R., Fujita, H., Sudarshan, V. K., Ghista, D. N., Lim, W. J. E., & Koh, J. E. 
W. (2015, 9-12 Oct. 2015). Automated Prediction of Sudden Cardiac Death Risk 
Using Kolmogorov Complexity and Recurrence Quantification Analysis Features 
Extracted from HRV Signals. Paper presented at the Systems, Man, and 
Cybernetics (SMC), 2015 IEEE International Conference on. 
Acharya, U. R., Fujita, H., Sudarshan, V. K., Sree, V. S., Eugene, L. W. J., Ghista, D. N., 
& San Tan, R. (2015). An integrated index for detection of sudden cardiac death 
using discrete wavelet transform and nonlinear features. Knowledge-Based 
Systems, 83, 149-158.  
Adabag, S., Rector, T. S., Anand, I. S., McMurray, J. J., Zile, M., Komajda, M., . . . 
Carson, P. E. (2014). A prediction model for sudden cardiac death in patients with 
heart failure and preserved ejection fraction. European journal of heart failure, 
16(11), 1175-1182.  
Agoston-Coldea, L., Bheecarry, K., Petra, C., Strambu, L., Ober, C., Revnic, R., . . . 
Fodor, D. (2018). The value of global longitudinal strain and galectin-3 for 
predicting cardiovascular events in patients with severe aortic stenosis. Medical 
ultrasonography, 20(2), 205-212.  
Al-Gobari, M., Le, H.-H., Fall, M., Gueyffier, F., & Burnand, B. (2017). No benefits of 
statins for sudden cardiac death prevention in patients with heart failure and 
reduced ejection fraction: A meta-analysis of randomized controlled trials. PloS 
one, 12(2), e0171168.  




Ayesta, A., Martínez-Sellés, H., de Luna, A. B., & Martínez-Sellés, M. (2018). Prediction 
of sudden death in elderly patients with heart failure. Journal of geriatric 
cardiology: JGC, 15(2), 185.  
Bagheri, M. A., & Gao, Q. (2012). An efficient ensemble classification method based on 
novel classifier selection technique. Paper presented at the Proceedings of the 2nd 




Bardy , G. H., Lee , K. L., Mark , D. B., Poole , J. E., Packer , D. L., Boineau , R., . . . Ip , 
J. H. (2005). Amiodarone or an Implantable Cardioverter–Defibrillator for 
Congestive Heart Failure. New England Journal of Medicine, 352(3), 225-237. 
doi:10.1056/NEJMoa043399 
Bauer, E., & Kohavi, R. (1998). An empirical comparison of voting classification 
algorithms: Bagging, boosting, and variants. Machine learning, 36(1), 2.  
Beleites, C., Neugebauer, U., Bocklitz, T., Krafft, C., & Popp, J. (2013). Sample size 
planning for classification models. Analytica chimica acta, 760, 25-33.  
Bellera, C. A., MacGrogan, G., Debled, M., de Lara, C. T., Brouste, V., & Mathoulin-
Pélissier, S. (2010). Variables with time-varying effects and the Cox model: Some 
statistical concepts illustrated with a prognostic factor study in breast cancer. 
BMC Medical Research Methodology, 10(1), 20. doi:10.1186/1471-2288-10-20 
Breiman, L. (1996). Bagging predictors. Machine learning, 24(2), 123-140.  
Darwiche, A., & Mukherjee, S. (2018). Machine Learning Methods for Septic Shock 
Prediction. Paper presented at the Proceedings of the 2018 International 
Conference on Artificial Intelligence and Virtual Reality. 
Deo, R., Norby, F. L., Katz, R., Sotoodehnia, N., Adabag, S., DeFilippi, C. R., . . . 
Folsom, A. R. (2016). Development and Validation of a Sudden Cardiac Death 
Prediction Model for the General PopulationClinical Perspective. Circulation, 
134(11), 806-816.  
Desai, M. Y., Smedira, N. G., Dhillon, A., Masri, A., Wazni, O., Kanj, M., . . . Lever, H. 
M. (2018). Prediction of sudden death risk in obstructive hypertrophic 
cardiomyopathy: potential for refinement of current criteria. The Journal of 
thoracic and cardiovascular surgery.  
Devi, R., Tyagi, H. K., & Kumar, D. (2016). Heart Rate Variability Analysis for Early 
Stage Prediction of Sudden Cardiac Death. World Academy of Science, 
Engineering and Technology, International Journal of Electrical, Computer, 
Energetic, Electronic and Communication Engineering, 10(3), 401-404.  
Deyell, M. W., Krahn, A. D., & Goldberger, J. J. (2015). Sudden cardiac death risk 
stratification. Circulation research, 116(12), 1907-1918.  
Dietterich, T. G. (2000). Ensemble methods in machine learning Multiple classifier 
systems (pp. 1-15): Springer. 
Dietterich, T. G. (2002). Ensemble learning. The handbook of brain theory and neural 




Dziura, J. D., Post, L. A., Zhao, Q., Fu, Z., & Peduzzi, P. (2013). Strategies for dealing 
with missing data in clinical trials: from design to analysis. The Yale journal of 
biology and medicine, 86(3), 343.  
Ebrahimzadeh, E., Fayaz, F., Ahmadi, F., & Dolatabad, M. R. (2018). Linear and 
nonlinear analyses for detection of sudden cardiac death (SCD) using ECG and 
HRV signals. Trends Med. Res., 1(1), 1-8.  
Ebrahimzadeh, E., & Pooyan, M. (2011). Early detection of sudden cardiac death by 
using classical linear techniques and time-frequency methods on 
electrocardiogram signals. Journal of Biomedical Science and Engineering, 4(11), 
699.  
Ebrahimzadeh, E., Pooyan, M., & Bijar, A. (2014). A novel approach to predict sudden 
cardiac death (SCD) using nonlinear and time-frequency analyses from HRV 
signals. PloS one, 9(2), e81896.  
Ejection fraction: What does it measure? (2018).   Retrieved from 
https://www.mayoclinic.org/ejection-fraction/expert-answers/FAQ-20058286 
Eranti, A., Aro, A. L., Kerola, T., Tikkanen, J. T., Rissanen, H. A., Anttonen, O., . . . 
Huikuri, H. V. (2016). Body Mass Index as a Predictor of Sudden Cardiac Death 
and Usefulness of the Electrocardiogram for Risk Stratification. The American 
journal of cardiology, 117(3), 388-393.  
Fan, X., Hua, W., Xu, Y., Ding, L., Niu, H., Chen, K., . . . Zhang, S. (2014). Incidence 
and predictors of sudden cardiac death in patients with reduced left ventricular 
ejection fraction after myocardial infarction in an era of revascularisation. Heart, 
heartjnl-2013-305144.  
Fishman, G. I., Chugh, S. S., DiMarco, J. P., Albert, C. M., Anderson, M. E., Bonow, R. 
O., . . . Jouven, X. (2010). Sudden cardiac death prediction and prevention report 
from a National Heart, Lung, and Blood Institute and Heart Rhythm Society 
workshop. Circulation, 122(22), 2335-2348.  
Forte, R. M. (2015). Mastering predictive analytics with R: Packt Publishing Ltd. 
Fox, J. (2002). Cox proportional-hazards regression for survival data. An R and S-PLUS 
companion to applied regression, 2002.  
Freund, Y., & Schapire, R. E. (1996). Experiments with a new boosting algorithm. Paper 
presented at the ICML. 
García Iglesias, D., Roqueñi Gutiérrez, N., De Cos, F. J., & Calvo, D. (2018). Analysis of 




Wavelet Transform: An Automatized Analysis for the Prediction of Sudden 
Cardiac Death. Sensors, 18(2), 560.  
Geurts, P., Ernst, D., & Wehenkel, L. (2006). Extremely randomized trees. Machine 
learning, 63(1), 3-42.  
Ghavidel, J., Yazdani, S., & Analoui, M. (2013, 28-30 May 2013). A new ensemble 
classifier creation method by creating new training set for each base classifier. 
Paper presented at the Information and Knowledge Technology (IKT), 2013 5th 
Conference on. 
Goldberger, J. J., Basu, A., Boineau, R., Buxton, A. E., Cain, M. E., Canty, J. M., . . . 
Exner, D. V. (2014). Risk stratification for sudden cardiac death a plan for the 
future. Circulation, 129(4), 516-526.  
Goldstein, B. A., Chang, T. I., Mitani, A. A., Assimes, T. L., & Winkelmayer, W. C. 
(2014). Near-term prediction of sudden cardiac death in older hemodialysis 
patients using electronic health records. Clinical Journal of the American Society 
of Nephrology, 9(1), 82-91.  
Gupta, R., Audhkhasi, K., & Narayanan, S. (2014, 4-9 May 2014). Training ensemble of 
diverse classifiers on feature subsets. Paper presented at the Acoustics, Speech 
and Signal Processing (ICASSP), 2014 IEEE International Conference on. 
Harrington, P. (2012). Machine Learning in Action: Manning Publications Co. 
Hastie, T., Tibshirani, R., & Friedman, J. (2009). The Elements of Statistical Learning 
(Second ed.): Springer. 
Ho, T. K. (1998). The random subspace method for constructing decision forests. Pattern 
Analysis and Machine Intelligence, IEEE Transactions on, 20(8), 832-844.  
Huikuri, H. V., Mäkikallio, T. H., Raatikainen, M. P., Perkiömäki, J., Castellanos, A., & 
Myerburg, R. J. (2003). Prediction of sudden cardiac death appraisal of the studies 
and methods assessing the risk of sudden arrhythmic death. Circulation, 108(1), 
110-115.  
Johansson, R., Bostrom, H., & Karlsson, A. (2008, 20-22 Aug. 2008). A study on class-
specifically discounted belief for ensemble classifiers. Paper presented at the 
Multisensor Fusion and Integration for Intelligent Systems, 2008. MFI 2008. 
IEEE International Conference on. 
Kakimoto, Y., Tanaka, M., Hayashi, H., Yokoyama, K., & Osawa, M. (2018). 
Overexpression of miR-221 in sudden death with cardiac hypertrophy patients. 




Kenward, M. G. (2013). The handling of missing data in clinical trials. Clinical 
Investigation, 3(3), 241-250.  
Klein, H., Auricchio, A., Reek, S., & Geller, C. (1999). New primary prevention trials of 
sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and 
MADIT-II. The American journal of cardiology, 83(5, Supplement 2), 91-97. 
doi:https://doi.org/10.1016/S0002-9149(99)00040-5 
Kotsiantis, S., Kanellopoulos, D., & Pintelas, P. (2006). Handling imbalanced datasets: A 
review. GESTS International Transactions on Computer Science and 
Engineering, 30(1), 25-36.  
Kubik, M., Dąbrowska-Kugacka, A., Lewicka, E., Daniłowicz-Szymanowicz, L., & 
Raczak, G. (2018). Predictors of poor outcome in patients with left ventricular 
noncompaction: Review of the literature. Advances in clinical and experimental 
medicine: official organ Wroclaw Medical University.  
Kurbanov, R. D., Mullabaeva, G. U., & Kilichev, A. A. (2015). Main Predictors of 
Sudden Cardiac Death in Patients with Q-Wave Myocardial Infarction. 
INTERNATIONAL JOURNAL OF BIOMEDICINE, 5(4), 195-197.  
Kursa, M. B., & Rudnicki, W. R. (2010). Feature selection with the Boruta package. J 
Stat Softw, 36(11), 1-13.  
Lantz, B. (2015). Machine Learning with R (Second ed.): Packt Publishing. 
Lee, H., Shin, S.-Y., Seo, M., Nam, G.-B., & Joo, S. (2016). Prediction of Ventricular 
Tachycardia One Hour before Occurrence Using Artificial Neural Networks. 
Scientific Reports, 6.  
Li, M., Chen, X., Chen, L., Chen, K., Zhou, J., & Song, J. (2018). MiR-1-3p that 
correlates with left ventricular function of HCM can serve as a potential target 
and differentiate HCM from DCM. Journal of translational medicine, 16(1), 161.  
Liew, R. (2011). Electrocardiogram‐Based Predictors of Sudden Cardiac Death in 
Patients With Coronary Artery Disease. Clinical cardiology, 34(8), 466-473.  
Mayo Clinic. (2018a). Hypertrophic cardiomyopathy.   Retrieved from 
https://www.mayoclinic.org/diseases-conditions/hypertrophic-
cardiomyopathy/symptoms-causes/syc-20350198 






Mayo Clinic Staff. (2016). Vasodilator.   Retrieved from 
https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/in-
depth/high-blood-pressure-medication/ART-20048154?p=1 
MedlinePlus. (2017a). Amiodarone.   Retrieved from 
https://medlineplus.gov/druginfo/meds/a687009.html 
MedlinePlus. (2017b). Contraindication.   Retrieved from 
https://medlineplus.gov/ency/article/002314.htm 
MedlinePlus. (2017c). Heart Failure.   Retrieved from 
https://medlineplus.gov/heartfailure.html 
Merriam-Webster Medical Dictionary. (2017).   Retrieved from https://www.merriam-
webster.com/dictionary/congestive%20heart%20failure 
Mohanty, M., Sahoo, S., Biswal, P., & Sabut, S. (2018). Efficient classification of 
ventricular arrhythmias using feature selection and C4. 5 classifier. Biomedical 
Signal Processing and Control, 44, 200-208.  
Murugappan, M., Murukesan, L., Omar, I., Khatun, S., & Murugappan, S. (2015). Time 
Domain Features Based Sudden Cardiac Arrest Prediction Using Machine 
Learning Algorithms. Journal of Medical Imaging and Health Informatics, 5(6), 
1267-1271.  
Murukesan, L., Murugappan, M., & Iqbal, M. (2013, 8-10 March 2013). Sudden cardiac 
death prediction using ECG signal derivative (Heart Rate Variability): A review. 
Paper presented at the Signal Processing and its Applications (CSPA), 2013 IEEE 
9th International Colloquium on. 
Murukesan, L., Murugappan, M., Iqbal, M., & Saravanan, K. (2014). Machine learning 
approach for sudden cardiac arrest prediction based on optimal heart rate 
variability features. Journal of Medical Imaging and Health Informatics, 4(4), 
521-532.  
Ng, G. A., Mistry, A., Li, X., Schlindwein, F. S., & Nicolson, W. B. (2018). LifeMap: 
towards the development of a new technology in sudden cardiac death risk 
stratification for clinical use. EP Europace.  
O'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., . . . 
McKenna, W. J. (2014). A novel clinical risk prediction model for sudden cardiac 
death in hypertrophic cardiomyopathy (HCM Risk-SCD). European heart 
journal, 35(30), 2010-2020.  
Özyılmaz, S., Satılmışoğlu, M. H., Gül, M., Uyarel, H., & Serdar, O. A. (2018). 




score of sudden cardiac death in five years in patients with hypertrophic 
cardiomyopathy. Turk Kardiyol Dern Ars, 46(2), 111-120.  
Parikh, R., Mathai, A., Parikh, S., Sekhar, G. C., & Thomas, R. (2008). Understanding 
and using sensitivity, specificity and predictive values. Indian journal of 
ophthalmology, 56(1), 45.  
Pascual-Figal, D. A., Ordoñez-Llanos, J., Tornel, P. L., Vázquez, R., Puig, T., Valdés, 
M., . . . Bayes-Genis, A. (2009). Soluble ST2 for predicting sudden cardiac death 
in patients with chronic heart failure and left ventricular systolic dysfunction. 
Journal of the American College of Cardiology, 54(23), 2174-2179.  
Piccini, J. P., Zhang, M., Pieper, K., Solomon, S. D., Al-Khatib, S. M., Van de Werf, F., . 
. . Velazquez, E. J. (2010). Predictors of sudden cardiac death change with time 
after myocardial infarction: results from the VALIANT trial. European heart 
journal, 31(2), 211-221.  
Rai, V., & Agrawal, D. K. (2016). Role of risk stratification and genetics in sudden 
cardiac death. Canadian journal of physiology and pharmacology, 95(3), 225-
238.  
Ramírez, J., Orini, M., & Laguna, E. P. P. (2017). Comparison of ECG T-wave Duration 
and Morphology Restitution Markers for Sudden Cardiac Death Prediction in 
Chronic Heart Failure. Computing, 44, 1.  
Ramírez, J., Orini, M., Mincholé, A., Monasterio, V., Cygankiewicz, I., Bayés de Luna, 
A., . . . Laguna, P. (2017). T‐Wave Morphology Restitution Predicts Sudden 
Cardiac Death in Patients With Chronic Heart Failure. Journal of the American 
Heart Association, 6(5). doi:10.1161/jaha.116.005310 
Ramos-Jimenez, G., del Campo-Avila, J., & Morales-Bueno, R. (2009, Nov. 30 2009-
Dec. 2 2009). Hybridizing Ensemble Classifiers with Individual Classifiers. Paper 
presented at the Intelligent Systems Design and Applications, 2009. ISDA '09. 
Ninth International Conference on. 
Refaeilzadeh, P., Tang, L., & Liu, H. (2009). Cross-Validation (pp. 532-538). 
Rosset, S., Domingo, A. M., Asimaki, A., Graf, D., Metzger, J., Schwitter, J., . . . Pruvot, 
E. (2018). Reduced Desmoplakin immunofluorescence signal in arrhythmogenic 
cardiomyopathy with epicardial right ventricular outflow tract tachycardia. 
HeartRhythm Case Reports.  
Royston, P., & Altman, D. G. (2013). External validation of a Cox prognostic model: 




Shastri, S., Tangri, N., Tighiouart, H., Beck, G. J., Vlagopoulos, P., Ornt, D., . . . Cheung, 
A. K. (2012). Predictors of sudden cardiac death: a competing risk approach in the 
hemodialysis study. Clinical Journal of the American Society of Nephrology, 7(1), 
123-130.  
Sheela, C. J., & Vanitha, L. (2014, 20-21 March 2014). Prediction of Sudden Cardiac 
Death using support vector machine. Paper presented at the Circuit, Power and 
Computing Technologies (ICCPCT), 2014 International Conference on. 
Shen, T.-W., Shen, H.-P., Lin, C.-H., & Ou, Y.-L. (2007, 22-26 Aug. 2007). Detection 
and Prediction of Sudden Cardiac Death (SCD) For Personal Healthcare. Paper 
presented at the Engineering in Medicine and Biology Society, 2007. EMBS 
2007. 29th Annual International Conference of the IEEE. 
Shiga, T., Kohro, T., Yamasaki, H., Aonuma, K., Suzuki, A., Ogawa, H., . . . Kasanuki, 
H. (2018). Body Mass Index and Sudden Cardiac Death in Japanese Patients After 
Acute Myocardial Infarction: Data From the JCAD Study and HIJAMI‐II 
Registry. Journal of the American Heart Association, 7(14), e008633.  
Skurichina, M., & Duin, R. P. (2002). Bagging, boosting and the random subspace 
method for linear classifiers. Pattern Analysis & Applications, 5(2), 121-135.  
Sotto, L. F. D. P., Coelho, R. C., & Melo, V. V. d. (2016). Classification of Cardiac 
Arrhythmia by Random Forests with Features Constructed by Kaizen 
Programming with Linear Genetic Programming. Paper presented at the 
Proceedings of the Genetic and Evolutionary Computation Conference 2016, 
Denver, Colorado, USA.  
Stecker, E. C., & Chugh, S. S. (2011). Prediction of sudden cardiac death: next steps in 
pursuit of effective methodology. Journal of interventional cardiac 
electrophysiology, 31(2), 101-107.  
Su, Y., Xia, M., Cao, J., & Gao, Q. (2018). Cardiac characteristics in the premature 
ventricular contraction patients with or without ventricular tachycardia. 
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL 
MEDICINE, 11(6), 6106-6112.  
Therneau, T., Crowson, C., & Atkinson, E. (2013). Using time dependent covariates and 
time dependent coefficients in the cox model. Red, 2, 1.  
Thomsen, M. B., Nielsen, M. S., Aarup, A., Bisgaard, L. S., & Pedersen, T. X. (2018). 
Uremia increases QRS duration after β‐adrenergic stimulation in mice. 




Toshniwal, D., Goel, B., & Sharma, H. (2015). Multistage Classification for 
Cardiovascular Disease Risk Prediction. Paper presented at the International 
Conference on Big Data Analytics. 
Vadakkumpadan, F., Trayanova, N., Younes, L., & Wu, K. C. (2012, Aug. 28 2012-Sept. 
1 2012). Left-ventricular shape analysis for predicting sudden cardiac death risk. 
Paper presented at the Engineering in Medicine and Biology Society (EMBC), 
2012 Annual International Conference of the IEEE. 
Valentini, G., & Masulli, F. (2002). Ensembles of learning machines Neural Nets (pp. 3-
20): Springer. 
Van Dijk, M., Steyerberg, E., Stenning, S., Dusseldorp, E., & Habbema, J. (2004). 
Survival of patients with nonseminomatous germ cell cancer: a review of the 
IGCC classification by Cox regression and recursive partitioning. British journal 
of cancer, 90(6), 1176.  
Vanitha, L., Suresh, G. R., & JenefarSheela, C. (2014, 13-14 Feb. 2014). Sudden Cardiac 
Death prediction system using Hybrid classifier. Paper presented at the 
Electronics and Communication Systems (ICECS), 2014 International Conference 
on. 
Verma, B., & Rahman, A. (2012). Cluster-Oriented Ensemble Classifier: Impact of 
Multicluster Characterization on Ensemble Classifier Learning. Knowledge and 
Data Engineering, IEEE Transactions on, 24(4), 605-618. 
doi:10.1109/TKDE.2011.28 
Walters, S. J. (2009). What is a Cox model?   Retrieved from 
https://pdfs.semanticscholar.org/5142/55da06320e50add5b2e6f00287c28c7b2168
.pdf 
Wang, S., Li, D., Petrick, N., Sahiner, B., Linguraru, M. G., & Summers, R. M. (2015). 
Optimizing area under the ROC curve using semi-supervised learning. Pattern 
Recognition, 48(1), 276-287. doi:https://doi.org/10.1016/j.patcog.2014.07.025 
Weeks, P. A., Sieg, A., Gass, J. A., & Rajapreyar, I. (2016). The role of pharmacotherapy 
in the prevention of sudden cardiac death in patients with heart failure. Heart 
failure reviews, 21(4), 415-431.  
Wellens, H. J., Schwartz, P. J., Lindemans, F. W., Buxton, A. E., Goldberger, J. J., 
Hohnloser, S. H., . . . Malik, M. (2014). Risk stratification for sudden cardiac 
death: current status and challenges for the future. European heart journal, 




Whalen, S., & Pandey, G. (2013, 7-10 Dec. 2013). A Comparative Analysis of Ensemble 
Classifiers: Case Studies in Genomics. Paper presented at the Data Mining 
(ICDM), 2013 IEEE 13th International Conference on. 
Yu, Z., Li, L., Liu, J., & Han, G. (2015). Hybrid Adaptive Classifier Ensemble. 
Cybernetics, IEEE Transactions on, 45(2), 177-190.  
Zhao, h. J. (2005). Mixed-effects Cox models of alcohol dependence in extended families. 
Paper presented at the BMC genetics. 
Zhou, M. (2001). Understanding the Cox Regression Models With Time-Change 
Covariates. The American Statistician, 55(2), 153-155. 
doi:10.1198/000313001750358491 
 
